Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tissue thermal ablation is a minimally invasive technique used to destroy abnormal tissue—including tumors and other lesions—by applying extreme heat or cold directly to the target area under image guidance. Heat-based approaches (such as radiofrequency ablation, microwave ablation, or focused ultrasound) induce cell death by coagulative necrosis, denaturing proteins and disrupting cell membranes. Cold-based approaches (cryoablation) freeze and rupture cells. The technique is widely used in oncology for tumors of the liver, lung, kidney, thyroid, uterus, and bone, as well as in the treatment of certain cardiac arrhythmias and chronic pain. Unlike molecular targets, thermal ablation is not a receptor or enzyme but an interventional procedure with evolving safety, efficacy, and application profiles[1][2][3][4][5][6]. Tissue thermal ablation, as presented here, is not a canonical drug target and should be excluded from lists of molecular or pharmacologic targets.
Induction of coagulative necrosis by heat (hyperthermia, e.g., radiofrequency, microwave, focused ultrasound) Induction of tissue death by freezing (cryoablation)[1][3][4][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue thermal ablation.